Literature DB >> 11808927

HIV testing among racial/ethnic minorities--United States, 1999.

.   

Abstract

Human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS) in the United States disproportionately affect racial/ethnic minority populations, particularly blacks and Hispanics. Of the 774,467 AIDS cases reported to CDC during June 1981-December 2000, blacks and Hispanics accounted for 56% of cases, although they represented 25% of the U.S. population during this period. In 2000, the incidence of adult and adolescent AIDS cases per 100,000 population was 74.2 for blacks, 30.4 for Hispanics, and 7.9 for whites. HIV counseling and testing services potentially can reduce the risk for infection with HIV and provide referrals to HIV-infected persons for medical care. An estimated 300,000 HIV-infected persons in the United States may be unaware of their HIV serostatus. In 2001, CDC introduced the Serostatus Approach to Fighting the Epidemic (SAFE), which focuses on increasing the number of high-risk and infected persons who know their serostatus and helps infected persons receive and maintain appropriate medical care and reduce their risk for transmitting infection. CDC analyzed data from the National Health Interview Survey (NHIS) to determine the rate at which racial/ethnic minorities are getting tested for HIV. This report describes the result of the analysis, which indicates that minority populations are being tested for HIV infection at a high rate; however, a substantial number of persons at risk for HIV have not been tested. Prevention programs should continue to develop innovative methods for counseling and testing at-risk persons.

Entities:  

Mesh:

Year:  2001        PMID: 11808927

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  8 in total

1.  HIV testing among U.S. women during prenatal care: findings from the 2002 National Survey of Family Growth.

Authors:  John E Anderson; Stephanie Sansom
Journal:  Matern Child Health J       Date:  2006-09

2.  Racial variance in rationale for HIV testing in community-based setting in the United States: evidence from the National Health Interview Survey.

Authors:  Laurens Holmes; Emmanuel Monjok; Doriel Ward; Orsolya M Garrison; Evette D Toney; Gbadebo Ogungbade; E James Essien
Journal:  J Int Assoc Physicians AIDS Care (Chic)       Date:  2008-03-04

3.  Racial/ethnic attitudes towards HIV testing in the primary care setting.

Authors:  Emma M Simmons; Michelle L Rogers; Georita M Frierson; Curt G Beckwith; Timothy P Flanigan
Journal:  J Natl Med Assoc       Date:  2005-01       Impact factor: 1.798

4.  HIV testing behaviors among undocumented Central American immigrant women in Houston, Texas.

Authors:  Jane R Montealegre; Jan M Risser; Beatrice J Selwyn; Keith Sabin; Sheryl A McCurdy
Journal:  J Immigr Minor Health       Date:  2012-02

5.  Characteristics of persons with heterosexually acquired HIV infection, United States 1999-2004.

Authors:  Lorena Espinoza; H Irene Hall; Felicia Hardnett; Richard M Selik; Qiang Ling; Lisa M Lee
Journal:  Am J Public Health       Date:  2006-11-30       Impact factor: 9.308

6.  Methods for recruiting men of color who have sex with men in prevention-for-positives interventions.

Authors:  Laura A Hatfield; Margherita E Ghiselli; Scott M Jacoby; Anne Cain-Nielsen; Gunna Kilian; Tara McKay; B R Simon Rosser
Journal:  Prev Sci       Date:  2010-03

7.  HIV screening in the health care setting: status, barriers, and potential solutions.

Authors:  Stacey A Rizza; Robin J MacGowan; David W Purcell; Bernard M Branson; Zelalem Temesgen
Journal:  Mayo Clin Proc       Date:  2012-09       Impact factor: 7.616

8.  HIV risk behaviors and testing history in historically black college and university settings.

Authors:  Peter E Thomas; Andrew C Voetsch; Binwei Song; Denyce Calloway; Carolyn Goode; Lynette Mundey; Joanne Nobles; Kaye Sly; Michelle R Smith; Brenda Williams; Mattie Shiloh; Kevin Patterson; Sybil Ward; Patrick S Sullivan; James D Heffelfinger
Journal:  Public Health Rep       Date:  2008 Nov-Dec       Impact factor: 2.792

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.